Receipt of anticancer medications or investigational drugs within Protocol-defined time frames.
Receipt of anticancer medications or investigational drugs within the following intervals before the first administration of study drug:
Receipt of anticancer chemotherapy within  weeks before the administration of study drug
Receipt of anticancer chemotherapy within  weeks before the first administration of study drug
Receipt of anticancer medications, anticancer therapies, or investigational drugs within the defined interval before the first administration of study drug.
Receipt of anticancer medications or investigational drugs within a defined interval before the first administration of study drug.
Receipt of anticancer medications, anticancer therapies, or investigational drugs within protocol-defined intervals before the first administration of study drug.
Receipt of any vitamin K antagonists, systemic corticosteroids, live vaccines, or treatment with any anticancer medications or investigational drugs within the protocol-defined intervals.
Receipt of anticancer medications or investigational drugs within protocol-specified intervals
Receipt of anticancer medications or investigational drugs within protocol-defined intervals before the first administration of study drug.
Receipt of anticancer medications or investigational drugs within a defined interval before the first administration of study drug.
Receipt of anticancer medications or investigational drugs within the Protocol-defined intervals before the first administration of study drug.
Receipt of anticancer medications or investigational drugs within a defined interval before the first administration of study drug.
Receipt of anticancer medications or investigational drugs within the following interval before the first administration of study drug:
Receipt of anticancer medications or investigational drugs within protocol-defined intervals before the first administration of study drug.
Treatment with other investigational study drug for any indication for any reason, or receipt of anticancer medications within  days before first dose of study drug; subjects must have recovered from AEs due to previously administered therapies.
Receipt of anticancer medications or investigational drugs within the protocol-defined intervals before the first administration of study drug.
Receipt of anticancer medications or investigational drugs within protocol-defined intervals before the first administration of study drug
